Reference
Puthenparampil M, et al. Lack of TFRin severe brain inflammation following alemtuzumab therapy. Clinical Neuropathology 36: 138, No. 3, Jun 2017 [abstract] - Italy
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1701, 17 (2018). https://doi.org/10.1007/s40278-018-45849-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-45849-7